The Horizons Marijuana Life Sciences Index ETF (TSE:HMMJ) (OTCMKTS:HMLSF) rallied through a current consolidation zone today, setting the stage for a test of the February high ($22.57) . The strong price action provided temporary clarity to a muddied technical picture, where Tier-1 leadership had been absent recently.
The sector leaders essentially moved in uniform fashion today. Leading the charge was Cronos Group, which finished up ↑6.67% on the day. Close behind were Aurora Cannabis ( ↑6.36%), Aphria ( ↑6.13%), and Canopy Growth ( ↑5.18%). The only major only partial joining-in was Tilray, which gained a modest ↑1.82%.
More importantly, every major except Tilray has formed a higher-high pivot on the hourly, suggesting whatever grip bears have mustered has dissipated. With all majors trading above their simple 200-day moving average, the predominant trend remains higher.
Even more impressive is the performance of select mid-majors—although this out-performance has been rotating between issues. OrganiGram Holdings was today’s big winner, surging 8.94% after signing a letter of intent with the Société Québécoise du Cannabis (SQDC) to offer their wares. A couple of sessions ago, it was CannTrust Holdings and Village Farms International that swelled on multi-day runs. Conspicuously absent from the festivities is Hexo Corp., which fell for the fourth straight session—although all daily losses have been modest.
The generally strong, upwards-grinding broad market price action has helped keep the bears in hibernation. Volume continues to trade generally below trend, which won’t serve to change the sector’s direction from bullish to bearish. Furthermore, HMMJ finished at session highs—above a 7-day consolidation zone. This bodes well heading into tomorrow’s session.
While there’s obviously no guarantees on what comes next, the path of least resistance is clearly higher. With heavily-weighted Tier-1 cannabis breaking higher to print pivot higher-highs on the hourly—and HMMJ itself doing the same—the benchmark ETF could produce some quick gains tomorrow.
A daily close above $22.57—on above trend volume—would be supportive for further upside extension in the days ahead.
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.